{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:56:22Z","timestamp":1790657782645,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016996","name":"Ahmadu Bello University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23115","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T10:44:23Z","timestamp":1701600263000},"page":"e23115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis"],"prefix":"10.1016","volume":"10","author":[{"given":"Salim Bitrus","family":"Anyubaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon Adamu","family":"Shallangwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamu","family":"Uzairu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Eyije","family":"Abechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/febs.15367","article-title":"Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni","volume":"288","author":"De Mori","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.heliyon.2023.e23115_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.635869","article-title":"Schistosomiasis morbidity hotspots: roles of the human host, the parasite and their interface in the development of severe morbidity","volume":"12","author":"Mawa","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23115_bib3","series-title":"Molecular Markers for Detecting Schistosoma Species by Loop-Mediated Isothermal Amplification","author":"Fern\u00e1ndez-Soto","year":"2020"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib4","first-page":"56","article-title":"Schistosomiasis in immigrants, refugees and travellers in an Italian referral centre for tropical diseases","volume":"7","author":"Marchese","year":"2018","journal-title":"Infectious diseases of poverty"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23115_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247312","article-title":"Current status of Schistosoma mansoni infection among previously treated rural communities in the Abbey and Didessa Valleys, Western Ethiopia: implications for sustainable control","volume":"16","author":"Assefa","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23115_bib6","article-title":"Epidemiology of schistosoma mansoni infection in ituri province, north-eastern democratic republic of the Congo","volume":"15","author":"Nigo","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib7","volume":"4","author":"McManus","year":"2018","journal-title":"Schistosomiasis. Nature Reviews Disease Primers"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/pathogens11030289","article-title":"From inflammation to fibrosis: novel insights into the roles of high mobility Group Protein Box 1 in Schistosome-induced liver damage","volume":"11","author":"Zhong","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.heliyon.2023.e23115_bib9","series-title":"Seminars in Immunopathology","first-page":"355","article-title":"Schistosomiasis\u2014from immunopathology to vaccines","volume":"vol. 42","author":"McManus","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e23115_bib10","series-title":"Risk Factors of Schistosomiasis and the Health Effect Among Patients Attending Alkalakla Health Centre-Khartoum State-Sudan","author":"Bahri","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e23115_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-019-3866-0","article-title":"The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in Schistosomiasis","volume":"12","author":"Chen","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.heliyon.2023.e23115_bib12","series-title":"Chronic Renal Disease","first-page":"149","article-title":"Ethnicity and chronic kidney disease in Africa","author":"Adu","year":"2020"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01402-5","article-title":"A multi-dimensional, time-lapse, high content screening platform applied to Schistosomiasis drug discovery","volume":"3","author":"Chen","year":"2020","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23115_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/vaccines9040322","article-title":"Structure, immunoreactivity, and in silico epitope determination of SmSPI S. Mansoni serpin for immunodiagnostic application","volume":"9","author":"De Benedetti","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.heliyon.2023.e23115_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114641","article-title":"Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects","volume":"242","author":"Rennar","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e23115_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.04.032","article-title":"Design, synthesis and anthelmintic activity of 7-keto-sempervirol analogues","volume":"152","author":"Crusco","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e23115_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2020.111257","article-title":"Molecular basis for hycanthone drug action in schistosome parasites","volume":"236","author":"Guzman","year":"2020","journal-title":"Mol. Biochem. Parasitol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23115_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005840","article-title":"Cysteine proteases as digestive enzymes in parasitic helminths","volume":"12","author":"Caffrey","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23115_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/acsinfecdis.0c00501","article-title":"Druggable hot spots in the Schistosomiasis cathepsin b1 target identified by functional and binding mode analysis of potent vinyl sulfone inhibitors","volume":"7","author":"J\u00edlkov\u00e1","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e23115_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.04.032","article-title":"Design, synthesis and anthelmintic activity of 7-keto-sempervirol analogues","volume":"152","author":"Crusco","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e23115_bib21","series-title":"In Silico Approach in Drug Design and Drug Discovery: an Update. Innovations And Implementations Of Computer Aided Drug Discovery Strategies In Rational Drug Design","first-page":"245","author":"Jabalia","year":"2021"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s42250-021-00250-y","article-title":"In silico design, drug-likeness and ADMET properties estimation of some substituted thienopyrimidines as HCV NS3\/4A protease inhibitors","volume":"4","author":"Ejeh","year":"2021","journal-title":"Chemistry Africa"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42269-021-00690-z","article-title":"In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative activity against triple negative breast cancer (MDA-MB231) cell line","volume":"46","author":"Abdullahi","year":"2022","journal-title":"Bull. Natl. Res. Cent."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23115_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bjbas.2018.03.010","article-title":"Optimization of the anticonvulsant activity of 2-acetamido-N-benzyl-2-(5-methylfuran-2-yl) acetamide using QSAR modeling and molecular docking techniques","volume":"7","author":"Adedirin","year":"2018","journal-title":"Beni-Suef University journal of basic and applied sciences"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s42250-020-00199-4","article-title":"In-silico design of aryl and aralkyl amine-based triazolopyrimidine derivatives with enhanced activity against resistant Plasmodium falciparum","volume":"4","author":"Ibrahim","year":"2021","journal-title":"Chemistry Africa"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01402-5","article-title":"A multi-dimensional, time-lapse, high content screening platform applied to Schistosomiasis drug discovery","volume":"3","author":"Chen","year":"2020","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23115_bib27","article-title":"Molecular modelling studies on triazole-based oxidoreductase inhibitor using 3D-QSAR","volume":"7","author":"Shrivastava","year":"2020","journal-title":"European Journal of Molecular and Clinical Medicine"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23115_bib28","first-page":"4322","article-title":"Molecular modelling studies on triazole-based oxidoreductase inhibitor using 3D-QSAR","volume":"7","author":"Porwal","year":"2021","journal-title":"European Journal of Molecular and Clinical Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s42250-020-00207-7","article-title":"QSAR, ligand-based design and pharmacokinetic studies of parviflorons derivatives as anti-breast cancer drug compounds against MCF-7 cell line","volume":"4","author":"Abdulrahman","year":"2021","journal-title":"Chemistry Africa"},{"key":"10.1016\/j.heliyon.2023.e23115_bib30","series-title":"IGI Global","article-title":"Computer Applications in Drug Discovery and Development","year":"2018"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jksus.2018.08.010","article-title":"Theoretical modeling for predicting the activities of some active compounds as potent inhibitors against Mycobacterium tuberculosis using GFA-MLR approach","volume":"32","author":"Adeniji","year":"2020","journal-title":"J. King Saud Univ. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.18596\/jotcsa.457618","article-title":"QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against leukemia cell line (K562)","volume":"5","author":"Mustapha","year":"2018","journal-title":"Journal of the Turkish Chemical Society Section A: Chemistry"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102514","article-title":"Modelling the anticancer activity of 4-alkoxy cinnamic analogues using 3D-descriptors and genetic algorithm-multiple linear regression (GA-MLR) method","volume":"35","author":"Rasyid","year":"2023","journal-title":"J. King Saud Univ. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23115_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jsps.2022.04.003","article-title":"Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches","volume":"30","author":"Bakal","year":"2022","journal-title":"Saudi Pharmaceut. J."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.18540\/jcecvl5iss3pp0283-0290","article-title":"QSAR study of 2-substituted phenyl-2-oxo-, 2-hydroxyl-and 2-acylloxyethylsulfonamides as fungicides","volume":"5","author":"Isyaku","year":"2019","journal-title":"The Journal of Engineering and Exact Sciences"},{"key":"10.1016\/j.heliyon.2023.e23115_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132291","article-title":"In silico design of novel PIN1 inhibitors by combined of 3D-QSAR, molecular docking, molecular dynamic simulation and ADMET studies","volume":"1253","author":"Tabti","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00126-9","article-title":"Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line","volume":"22","author":"Umar","year":"2021","journal-title":"Egyptian Journal of Medical Human Genetics"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23115_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03639","article-title":"Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents","volume":"6","author":"Adeniji","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2023.e23115_bib39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10989-019-09939-8","article-title":"In silico design of novel tetra-substituted pyridinylimidazoles derivatives as c-jun N-terminal kinase-3 inhibitors, using 2D\/3D-QSAR studies, molecular docking and ADMET prediction","volume":"26","author":"El Aissouq","year":"2020","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e23115_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmgm.2018.11.019","article-title":"Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: insight into mechanism of interactions and parameters for design of new inhibitors","volume":"87","author":"Safarizadeh","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2023.e23115_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2021.100783","article-title":"Activity modeling, molecular docking and pharmacokinetic studies of some boron-pleuromutilins as anti-wolbachia agents with potential for treatment of filarial diseases","volume":"36","author":"Ugbe","year":"2021","journal-title":"Chemical Data Collections"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-05964-z","article-title":"A simple, robust and efficient computational method for n-octanol\/water partition coefficients of substituted aromatic drugs","volume":"7","author":"Bahmani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e23115_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-020-00027-z","article-title":"Computational modeling and ligand-based design of some novel hypothetical compound as prominent inhibitors against Mycobacterium tuberculosis","volume":"6","author":"Adeniji","year":"2020","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s43094-022-00420-w","article-title":"2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease","volume":"8","author":"Ajala","year":"2022","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-score\u2013a comprehensive scoring function for evaluation of chemical drug-likeness","volume":"10","author":"Guan","year":"2019","journal-title":"Medchemcomm"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23115_bib46","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/cpt.1667","article-title":"Transforming translation through quantitative pharmacology for high\u2010impact decision making in drug discovery and development","volume":"107","author":"Gupta","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23115_bib47","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/07391102.2020.1819878","article-title":"In silico drug discovery of IKK-\u03b2 inhibitors from 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl) pyridine derivatives based on QSAR, docking, molecular dynamics and drug-likeness evaluation studies","volume":"40","author":"Hammoudi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2023.e23115_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1206872","article-title":"Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents","volume":"14","author":"Akash","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2023.e23115_bib49","article-title":"In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug-likeness evaluation","volume":"1229","author":"Sobhi","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23115_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/1570180818666210114115415","article-title":"Computational bioactivity analysis and bioisosteric investigation of the approved breast cancer drugs proposed new design drug compounds: increased bioactivity coming with silicon and boron","volume":"18","author":"Dogan","year":"2021","journal-title":"Lett. Drug Des. Discov."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23115_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/zpch-2021-3119","article-title":"Binding interaction of benzamide derivatives as inhibitors of DNA gyrase and Sec14p using Molegro Virtual Docker based on binding free energy","volume":"236","author":"Ihsan","year":"2022","journal-title":"Z. Phys. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23115_bib52","first-page":"300","article-title":"Targeting NM23-H1-mediated inhibition of tumour metastasis in viral hepatitis with bioactive compounds from Ganoderma lucidum: a computational study","volume":"82","author":"Kumar","year":"2020","journal-title":"Indian J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23115_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/2314808X.2022.2050115","article-title":"Molecular docking, ADMET and pharmacokinetic properties predictions of some di-aryl pyridinamine derivatives as estrogen receptor (Er+) kinase inhibitors","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Egyptian Journal of Basic and Applied Sciences"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23115_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07463","article-title":"QSAR, molecular docking and ADMET properties in silico studies of novel 4, 5, 6, 7-tetrahydrobenzo [D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase","volume":"7","author":"Daoui","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2023.e23115_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1018694","article-title":"QSAR modeling and molecular docking analysis of some active compounds against mycobacterium tuberculosis receptor (Mtb CYP121)","author":"Adeniji","year":"2018","journal-title":"Journal of pathogens"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23115_bib56","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtumed.2023.04.005","article-title":"Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodiumfalciparum","volume":"18","author":"Ibrahim","year":"2023","journal-title":"Journal of Taibah University Medical Sciences"},{"key":"10.1016\/j.heliyon.2023.e23115_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2022.100911","article-title":"Ligand-based drug design, molecular docking and pharmacokinetic studies of some series of 1, 4-dihydropyridines derivatives as human intestinal maltase-glucoamylase inhibitor","volume":"41","author":"Aminu","year":"2022","journal-title":"Chemical Data Collections"},{"key":"10.1016\/j.heliyon.2023.e23115_bib58","series-title":"Computational Toxicology (Pp. 3\u201353","article-title":"Molecular descriptors for structure\u2013activity applications: a hands-on approach","volume":"vol. 1800","author":"Grisoni","year":"2018"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23115_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12339","article-title":"Antihypertensive activity of roasted cashew nut in mixed petroleum fractions-induced hypertension: an in vivo and in silico approaches","volume":"8","author":"Akintunde","year":"2022","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23115_bib60","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.3390\/ijms23116093","article-title":"Active compounds in Zingiber officinale as possible redox inhibitors of 5-lipoxygenase using an in silico approach","volume":"23","author":"Ley-Mart\u00ednez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e23115_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.115611","article-title":"Ni (II) mixed-ligand chelates based on 2-hydroxy-1-naphthaldehyde as antimicrobial agents: synthesis, characterization, and molecular modeling","volume":"330","author":"Ismael","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"2-s","key":"10.1016\/j.heliyon.2023.e23115_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.22270\/jddt.v9i2-s.2710","article-title":"In vitro ADME studies of TUG-891, a GPR-120 inhibitor using SWISS ADME predictor","volume":"9","author":"Mishra","year":"2019","journal-title":"J. Drug Deliv. Therapeut."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023103239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023103239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:17:17Z","timestamp":1790655437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023103239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023103239"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23115","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23115"}}